Prevelance, Predictors and Outcome of Sepsis Associated Liver Injury (SALI)

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06758908

Enrollment

100

Registered

2025-01-06

Start date

2025-04-30

Completion date

2026-10-31

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Injuries

Brief summary

prevelance, predictors and outcome of sepsis associated liver injury (SALI)

Detailed description

patient with liver disease and sepsis at the same time

Interventions

DEVICEAntibiotic

SALI

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

15 Years to 75 Years

Healthy volunteers

Inclusion criteria

* clinical diagnosis of SALI * must take liver support

Exclusion criteria

* SALI * Thyroid disease

Design outcomes

Primary

Measure	Time frame	Description
prevelance, predictors and outcome of sepsis associated liver injury (SALI)	baseline	analysis outcome of sepsis associated liver injury (SALI)
28 days mortality	baseline	patient with liver dieases and sepsis
patient shouldn't be in pain	baseline	patient in study not in pain

Secondary

Measure	Time frame	Description
patient stay in hospital 2weeks	baseline	patient with liver dieases and sepsis

Contacts

Primary ContactMahmoud sayed zohry, first mastar

mzohry789@yahoo.com01225463889

Backup ContactDinal ali hamad dina hamad, specialist

dinaalihamad@aun.edu01063040703

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026